Presentation Miami Valves 2024 Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis Presenter: Thomas E. Noel February 01, 2024
Presentation ARCH 2019 The Current Status and Future of Interventional Cardiology Presenter: Jeffrey W. Moses April 12, 2019
Presentation CDM 2017 From Andreas Gruentzig to PCSK9: How Angioplasty Transformed Cardiovascular Care Presenter: Spencer B. King October 06, 2017
Presentation VIVA 2017 Results from the IN.PACT SFA Randomized Trial Presenter: Peter A. Schneider September 15, 2017
Presentation JIM 2017 AngiosculptX Drug-coated PTCA Scoring Balloon: Findings from Pre-clinical and Clinical Experience Presenter: Robert A. Byrne February 10, 2017
Presentation CHIP Florida 2017 Multivessel Disease and Low EF Case Presenter: Raja Hatem January 21, 2017
Presentation CCVVC 2016 New technologies for the treatment of PAD: What’s happening outside the US? Presenter: Jos C. van den Berg June 15, 2016
Presentation SOLACI 2016 Is There Any Reason To Do Aspiration Thrombectomy During Primary Angioplasty? Presenter: Eric R. Bates June 10, 2016
Presentation EuroPCR 2016 A Randomised Comparison Between Drug-Eluting Balloon and Conventional Balloon Angioplasty for Lesions in The Penile Artery in Patients With Erectile Dysfunction: The PEFECT-4 Study Presenter: Tzung-Dau Wang May 18, 2016
Presentation JIM 2016 Excimer laser facilitated coronary angioplasty of a heavy calcified lesion treated with drug eluting stents Presenter: Antonio Mangieri February 12, 2016
Presentation Late Restenosis After Paclitaxel-Coated Balloon Angioplasty in Patients With DES Restenosis Presenter: Seiji Habara June 30, 2015
Presentation TCT 2014 Sirolimus-Eluting Balloon Angioplasty Dilatation System for ISR Indication: The SABRE Trial Presenter: Todd J. Brinton, Ian T. Meredith, Greg L. Kaluza, Stefan Verheye September 16, 2014
Presentation TCT 2014 TCT 270: Comparison Among a Drug-Eluting Balloon, Drug-Eluting Stent, and Plain Balloon Angioplasty for Treatment of In-Stent Restenosis: A Network Meta-analysis of 11 Randomized Controlled Trials Presenter: John A. Bittl, Tullio Palmerini, Joo Myung Lee, MD September 15, 2014
Presentation TCT 2014 DES Systems and Outcomes Presenter: Manish A. Parikh, Robert T. Pyo, Jonathan Feig, Ziad A. Ali September 12, 2014
Presentation TCT 2013 LEVANT 2: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs. Standard Balloon Angioplasty in Diseased Femoropopliteal Arteries Presenter: Kenneth Rosenfield October 30, 2013
Presentation TCT 2013 RIBS V: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty vs. Everolimus-Eluting Stents in Bare Metal In-Stent Restenosis Presenter: Fernando Alfonso October 30, 2013
Presentation A Randomized Comparison of Paclitaxel-coated Balloon Catheter With Conventional Balloon Angioplasty In Patients With BMS, DES Restenosis Presenter: Seiji Habara September 23, 2013
Presentation Drug-Eluting Balloon in Peripheral Intervention for Below-the-Knee Angioplasty Evaluation Presenter: Francesco Liistro July 01, 2013
Presentation Paclitaxel-Eluting Balloons, Paclitaxel-Eluting Stents, and Balloon Angioplasty in Patients with Restenosis After DES Implantation Presenter: Robert A. Byrne February 07, 2013
Presentation TCT 2013 Cost-effectiveness of paclitaxel-coated balloon angioplasty for treatment of coronary restenosis in bare-metal stents Presenter: Klaus Bonaventura, Alexander Leber, Christian Sohns, Mattias Roser, Leif-Hendrik Boldt, Wilhelm Haverkamp, Marc Dorenkamp January 31, 2013